The role of carotid arterial intima-media thickness in predicting clinical coronary events

被引:997
作者
Hodis, HN
Mack, WJ
LaBree, L
Selzer, RH
Liu, CR
Liu, CH
Azen, SP
机构
[1] Univ So Calif, Sch Med, Div Cardiol, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA
[2] CALTECH, Pasadena, CA 91125 USA
[3] Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA
关键词
coronary arteriosclerosis; carotid artery diseases; ultrasonography; tunica intima; tunica media;
D O I
10.7326/0003-4819-128-4-199802150-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Carotid arterial intima-media thickness is used as a noninvasive surrogate end point to measure progression of atherosclerosis, but its relation to coronary events has not been fully explored. Objective: To determine whether carotid arterial intimamedia thickness predicts coronary events. Design: Long-term follow-up (average, 8.8 years) of a previously assembled cohort of persons who completed the 2-year Cholesterol Lowering Atherosclerosis Study, a randomized arterial imaging trial designed to study the effects of lipid lowering on progression of atherosclerosis. Setting: University-based ultrasonography laboratory. Patients: 146 men 40 to 59 years of age who had previously had coronary artery bypass graft surgery. Measurements: Preintrusive atherosclerosis in the common carotid artery was evaluated every 6 months with B-mode ultrasonography, and intrusive atherosclerosis in the coronary arteries was evaluated at baseline and at 2 years with quantitative coronary angiography. After the trial, the incidences of coronary events (nonfatal acute myocardial infarction, coronary death, and coronary artery revascularization) were documented. Results: For each 0.03-mm increase per year in carotid arterial intima-media thickness, the relative risk for non-fatal myocardial infarction or coronary death was 2.2 (95 % Cl, 1.4 to 3.6) and the relative risk for any coronary event was 3.1 (Cl, 2.1 to 4.5) (P < 0.001). Absolute intima-media thickness was also related to risk for clinical coronary events (P < 0.02). Absolute thickness and progression in thickness predicted risk for coronary events beyond that predicted by coronary arterial measures of atherosclerosis and lipid measurements (P < 0.001). Conclusion: Noninvasive B-mode ultrasonographic measurement of progression of intima-media thickness in the distal common carotid artery is a useful surrogate end point for clinical coronary events.
引用
收藏
页码:262 / +
页数:9
相关论文
共 27 条
[1]   Progression of coronary artery disease predicts clinical coronary events - Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study [J].
Azen, SP ;
Mack, WJ ;
CashinHemphill, L ;
LaBree, L ;
Shircore, AM ;
Selzer, RH ;
Blankenhorn, DH ;
Hodis, HN .
CIRCULATION, 1996, 93 (01) :34-41
[2]   Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study [J].
Belcaro, G ;
Nicolaides, AN ;
Laurora, G ;
Cesarone, MR ;
DeSanctis, M ;
Incandela, L ;
Barsotti, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (07) :851-856
[3]   CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS) [J].
BLANKENHORN, DH ;
AZEN, SP ;
KRAMSCH, DM ;
MACK, WJ ;
CASHINHEMPHILL, L ;
HODIS, HN ;
DEBOER, LWV ;
MAHRER, PR ;
MASTELLER, MJ ;
VAILAS, LI ;
ALAUPOVIC, P ;
HIRSCH, LJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (10) :969-976
[4]   PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS [J].
BLANKENHORN, DH ;
ALAUPOVIC, P ;
WICKHAM, E ;
CHIN, HP ;
AZEN, SP .
CIRCULATION, 1990, 81 (02) :470-476
[5]   ARTERIAL IMAGING AND ATHEROSCLEROSIS REVERSAL [J].
BLANKENHORN, DH ;
HODIS, HN .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (02) :177-192
[6]   BENEFICIAL-EFFECTS OF COLESTIPOL-NIACIN THERAPY ON THE COMMON CAROTID-ARTERY - 2-YEAR AND 4-YEAR REDUCTION OF INTIMA-MEDIA THICKNESS MEASURED BY ULTRASOUND [J].
BLANKENHORN, DH ;
SELZER, RH ;
CRAWFORD, DW ;
BARTH, JD ;
LIU, CR ;
LIU, CH ;
MACK, WJ ;
ALAUPOVIC, P .
CIRCULATION, 1993, 88 (01) :20-28
[7]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240
[8]   EFFECTS OF COLESTIPOL-NIACIN THERAPY ON HUMAN FEMORAL ATHEROSCLEROSIS [J].
BLANKENHORN, DH ;
AZEN, SP ;
CRAWFORD, DW ;
NESSIM, SA ;
SANMARCO, ME ;
SELZER, RH ;
SHIRCORE, AM ;
WICKHAM, EC .
CIRCULATION, 1991, 83 (02) :438-447
[9]   THE CHOLESTEROL LOWERING ATHEROSCLEROSIS STUDY (CLAS) - DESIGN, METHODS, AND BASELINE RESULTS [J].
BLANKENHORN, DH ;
JOHNSON, RL ;
NESSIM, SA ;
AZEN, SP ;
SANMARCO, ME ;
SELZER, RH .
CONTROLLED CLINICAL TRIALS, 1987, 8 (04) :354-387
[10]   CHANGES IN SEQUENTIAL CORONARY ARTERIOGRAMS AND SUBSEQUENT CORONARY EVENTS [J].
BUCHWALD, H ;
MATTS, JP ;
FITCH, LL ;
CAMPOS, CT ;
SANMARCO, ME ;
AMPLATZ, K ;
CASTANEDAZUNIGA, WR ;
HUNTER, DW ;
PEARCE, MB ;
BISSETT, JK ;
EDMISTON, WA ;
SAWIN, HS ;
WEBER, FJ ;
VARCO, RL ;
CAMPBELL, GS ;
YELLIN, AE ;
SMINK, RD ;
LONG, JM ;
HANSEN, BJ ;
CHALMERS, TC ;
MEIER, P ;
STAMLER, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (11) :1429-1433